We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Applied Biosystems Completes Equity Investment in VisiGen

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "Applied Biosystems Completes Equity Investment in VisiGen"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

Applied Biosystems Group, an Applera Corporation business, has announced that it has completed its previously announced equity investment in privately held VisiGen Biotechnologies.

Concurrent with its investment, Applied Biosystems also entered into a scientific collaboration agreement with VisiGen.

The VisiGen investment is part of Applied Biosystems’ strategy of maintaining its position in DNA sequencing by complementing its internal investments in new and existing sequencing technologies with promising next-generation approaches.

VisiGen’s technological approach to DNA sequencing is based on the ability to analyze a single molecule of DNA in real-time.